Literature DB >> 24102813

An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps.

Eva Compérat1, Lars Egevad, Antonio Lopez-Beltran, Philippe Camparo, Ferran Algaba, Mahul Amin, Jonathan I Epstein, Hans Hamberg, Christina Hulsbergen-van de Kaa, Glen Kristiansen, Rodolfo Montironi, Chin-Chen Pan, Fabrice Heloir, Kilian Treurniet, Jenna Sykes, Theo H Van der Kwast.   

Abstract

AIMS: The distinction between non-invasive (pTa) and invasive (pT1) non-muscle invasive bladder cancer (NMIBC) is subject to considerable interobserver variation. We aimed to generate a teaching set of images based on the diagnostic opinions of a panel of expert genitourinary pathologists. METHODS AND
RESULTS: Twenty-five transurethral resection specimens initially reported as pT1 NMIBC from two university hospitals were selected on the basis of potential uncertainty of stromal invasion. Digitized slides were reviewed independently by a panel of eight genitourinary pathologists, who annotated any invasive area if present. Annotations were reviewed by the lead panel, and heatmaps of annotated areas were constructed. Reasons for discrepancies were analysed, and kappa scores were calculated to determine agreement among the eight panellists. Full agreement by the eight panellists was obtained in 11 of 25 cases (44%), with a multi-rater (Fleiss) kappa of 0.47 (P < 0.0001). After joint review of the seven discordant (agreement <75% of panellists) cases, consensus was obtained for six cases, and a teaching set of images was generated.
CONCLUSIONS: Interobserver agreement among the panellists in the selected cases was moderate, but consensus could be reached in almost all cases. Heatmaps proved to be instrumental in generating a teaching set of images for standardization of histological criteria for NMIBC invasion.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  bladder cancer; interobserver variation; pT1 bladder cancer; pathological stage; virtual microscopy

Mesh:

Year:  2013        PMID: 24102813     DOI: 10.1111/his.12214

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  SIU-ICUD on bladder cancer: pathology.

Authors:  Eva Compérat; Marek Babjuk; Ferran Algaba; Mahul Amin; Fadi Brimo; David Grignon; Donna Hansel; Ondra Hes; Bernard Malavaud; Victor Reuter; Theo van der Kwast
Journal:  World J Urol       Date:  2018-09-14       Impact factor: 4.226

Review 2.  A practical guide to bladder cancer pathology.

Authors:  Eva Compérat; Justine Varinot; Julien Moroch; Caroline Eymerit-Morin; Fadi Brimo
Journal:  Nat Rev Urol       Date:  2018-01-31       Impact factor: 14.432

3.  A paired kappa to compare binary ratings across two medical tests.

Authors:  Kerrie P Nelson; Don Edwards
Journal:  Stat Med       Date:  2019-05-17       Impact factor: 2.373

Review 4.  Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.

Authors:  Eva Compérat; André Oszwald; Gabriel Wasinger; Donna E Hansel; Rodolfo Montironi; Theodorus van der Kwast; Johannes A Witjes; Mahul B Amin
Journal:  World J Urol       Date:  2021-09-23       Impact factor: 3.661

5.  Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link.

Authors:  Karim Chamie; Eric Ballon-Landa; Jeffrey C Bassett; Timothy J Daskivich; Meryl Leventhal; Dennis Deapen; Mark S Litwin
Journal:  Cancer       Date:  2014-10-22       Impact factor: 6.921

Review 6.  Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.

Authors:  Roberta Mazzucchelli; Daniela Marzioni; Giovanni Tossetta; Laura Pepi; Rodolfo Montironi
Journal:  Front Surg       Date:  2021-12-02

Review 7.  Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis.

Authors:  David Oswald; Maximilian Pallauf; Susanne Deininger; Peter Törzsök; Manuela Sieberer; Christian Eiben
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

8.  Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.

Authors:  Carlo Patriarca; Rodolfo Hurle; Marco Moschini; Massimo Freschi; Piergiuseppe Colombo; Maurizio Colecchia; Lucia Ferrari; Giorgio Guazzoni; Andrea Conti; Giario Conti; Roberta Lucianò; Tiziana Magnani; Renzo Colombo
Journal:  Diagn Pathol       Date:  2016-01-20       Impact factor: 2.644

9.  Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.

Authors:  Kyungtae Ko; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.